MDMAT

Entactogen drug From Wikipedia, the free encyclopedia

MDMAT, also known as 6,7-methylenedioxy-N-methyl-2-aminotetralin, is a serotonin releasing agent (SRA) and possible entactogen of the 2-aminotetralin family. It is the N-methylated derivative of MDAT, similarly to the relationship of MDMA to MDA.[2][3] It has been theorized to have less long-term neurotoxicity and less hallucinogenic effects than other MDxx derivatives,[4] but no formal scientific research has been conducted specifically on MDMAT.

Other names6,7-MDMAT; 6,7-Methylenedioxy-N-methyl-2-aminotetralin
ATC code
  • None
Legal status
  • US: Uncontrolled;[1] May fall under the Federal Analogue Act
Quick facts Clinical data, Other names ...
MDMAT
Clinical data
Other names6,7-MDMAT; 6,7-Methylenedioxy-N-methyl-2-aminotetralin
Drug classSerotonin releasing agent; Entactogen
ATC code
  • None
Legal status
Legal status
  • US: Uncontrolled;[1] May fall under the Federal Analogue Act
Identifiers
  • N-Methyl-5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxol-6-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H15NO2
Molar mass205.257 g·mol−1
3D model (JSmol)
  • C3c1cc2OCOc2cc1CCC3NC
  • InChI=1S/C12H15NO2/c1-13-10-3-2-8-5-11-12(15-7-14-11)6-9(8)4-10/h5-6,10,13H,2-4,7H2,1H3 ☒N
  • Key:MTRLJTZQUZHTJI-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)
Close

See also

References

Related Articles

Wikiwand AI